Importantly, FOXP1 belongs to the most reproducibly assessable markers in DLBCL as shown in an international inter- and intra-institutional and inter- and intra-observer study [58], further calling for its regular evaluation. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.